PALO ALTO, Calif., Sept. 14, 2019 /PRNewswire/ -- Stanford Health Care is inviting the community to experience a behind the scenes multimedia tour of the new Stanford Hospital, an 824,000 square foot facility that will transform the way that patient care is delivered at Stanford.

WASHINGTON, Sept. 14, 2019 /PRNewswire/ -- American Humane, the country's first national humane organization, which has been saving animals in disasters for more than 100 years, is dep

SACRAMENTO, Calif., Sept. 14, 2019 /PRNewswire/ -- The undersigned organizations condemn the behavior of Rebecca Dalelio who allegedly threw a red liquid from the Senate gallery that struck some CA State Senators. We are thankful that no Senator was injured in the

ANN ARBOR, Mich., Sept. 13, 2019 /PRNewswire/ -- FINNEA Group, LLC ("FINNEA") is pleased to announce the successful growth financing capital raise by Xoran Holdings LLC ("Xoran").  FINNEA acted as the exclusive financial advisor to Xoran.

WARSAW, Ind., Sept. 13, 2019 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, will participate in the 2019 Cantor Global Healthcare Conference at the InterContinental New York Barclay Hotel in New York.  Cole Lannum, CFA, Senior Vice President of Investor Relations, will present for the compa

THOUSAND OAKS, Calif., Sept. 13, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Bank of America Merrill Lynch Global Healthcare Conference at 9:45 a.m. British Summer Time on Wednesday, Sept. 18, 2019, in London. David W. Meline,

LAS VEGAS, Sept. 13, 2019 /PRNewswire/ -- Greenery Map, the world's first and only cannabis search engine to allow users to search for cannabis products based on their desired mood, me

NEW YORK, Sept. 13, 2019 /PRNewswire/ -- Synapse Medical Communications (Synapse), a leader in analytics-driven commercialization solutions, announced tha

WASHINGTON, Sept. 13, 2019 /PRNewswire/ -- Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on the Health and Human Services Officer of Inspector General

WOBURN, Mass., Sept. 13, 2019 /PRNewswire/ -- Glycosyn LLC, a maker of human milk oligosaccharides (HMOs) which are key ingredients in widely-used baby formula Similac® today announced that an International Trade Commission administrative law judge has issued a Notice of Initial Determination that Jennewein Biotechnologie GmbH has infringed Glycosyn's U.S.